We are live on !
Find out more
Baird Portfolio holdings
AUM
$9.8B
Turnover
14.34%
1-Year Est. Return
11.39%
This Fund
S&P 500
This Quarter Est. Return
+2.57%
1 Year Est. Return
+11.39%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$9.8B
AUM Growth
+$385M
(+4.1%)
Cap. Flow
+$249M
Cap. Flow % of AUM
Cap. Flow %
2.54%
Top 10 Holdings %
Top 10 Hldgs %
13.83%
Holding
1,388
New
121
Increased
618
Reduced
511
Closed
78
Avg Time Held
1.2
years
Top 10 Avg Time Held
1.3
years
Top 20 Avg Time Held
1.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$65.4M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$63.5M |
| 3 |
iShares Russell 1000 Value ETF
IWD
|
+$44.4M |
| 4 |
State Street SPDR EURO STOXX 50 ETF
FEZ
|
+$42.1M |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
+$39.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HSP
HOSPIRA INC
HSP
|
+$54.3M |
| 2 |
PVH
PVH
|
+$43M |
| 3 |
Walmart Inc
WMT
|
+$33M |
| 4 |
VIAB
Viacom Inc. Class B
VIAB
|
+$30.3M |
| 5 |
Cardinal Health
CAH
|
+$28.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 21.36% |
| 2 | Technology | 13.6% |
| 3 | Industrials | 12.32% |
| 4 | Healthcare | 12.1% |
| 5 | Consumer Discretionary | 10.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
251
iShares MSCI EAFE Small-Cap ETF
SCZ
$12.9B
| $7.56M | 0.08% |
152,870
-19,258
| -11% | -$931K |
2013 Q2
7 quarters
|
|
252
iShares Russell Mid-Cap Value ETF
IWS
$15.6B
| $7.52M | 0.08% |
99,899
+3,325
| +3% | +$248K |
2013 Q2
7 quarters
|
|
253
Eli Lilly
LLY
$1.13T
| $7.51M | 0.08% |
103,383
+329
| +0.3% | +$23.4K |
2013 Q2
7 quarters
|
|
254
State Street SPDR S&P Pharmaceuticals ETF
XPH
$460M
| $7.51M | 0.08% |
121,536
+2,228
| +2% | +$132K |
2013 Q2
7 quarters
|
|
255
Travelers Companies
TRV
$82.4B
| $7.48M | 0.08% |
69,221
+25,076
| +57% | +$2.68M |
2013 Q2
7 quarters
|
|
256
First Trust Large Cap Value AlphaDEX Fund
FTA
$1.4B
| $7.48M | 0.08% |
170,972
+14,882
| +10% | +$651K |
2013 Q2
7 quarters
|
|
257
State Street SPDR S&P Dividend ETF
SDY
$21.7B
| $7.48M | 0.08% |
95,586
-4,954
| -5% | -$389K |
2013 Q2
7 quarters
|
|
258
Thermo Fisher Scientific
TMO
$257B
| $7.41M | 0.08% |
55,165
+1,008
| +2% | +$130K |
2013 Q2
7 quarters
|
|
259
General Motors
GM
$66.8B
| $7.36M | 0.08% |
196,319
+28,115
| +17% | +$1.02M |
2013 Q2
7 quarters
|
|
260
Expeditors International
EXPD
$25.8B
| $7.31M | 0.07% |
151,801
-38,405
| -20% | -$1.77M |
2013 Q2
7 quarters
|
|
261
Lands' End
LE
$287M
| $7.29M | 0.07% |
203,266
+37,741
| +23% | +$1.5M |
2014 Q2
3 quarters
|
|
262
Amazon
AMZN
$2.85T
| $7.27M | 0.07% |
390,940
-156,060
| -29% | -$2.74M |
2013 Q2
7 quarters
|
|
263
Novartis
NVS
$292B
| $7.24M | 0.07% |
81,899
-5,965
| -7% | -$529K |
2013 Q2
7 quarters
|
|
264
Clorox
CLX
$10.3B
| $7.23M | 0.07% |
65,477
+3,074
| +5% | +$334K |
2013 Q2
7 quarters
|
|
265
Methode Electronics
MEI
$524M
| $7.22M | 0.07% |
153,515
+27,520
| +22% | +$1.1M |
2014 Q2
3 quarters
|
|
266
LTC Properties
LTC
$2.29B
| $7.18M | 0.07% |
156,122
+27,013
| +21% | +$1.22M |
2013 Q2
7 quarters
|
|
267
Invesco Dorsey Wright Momentum ETF
PDP
$1.46B
| $7.13M | 0.07% |
164,082
-12,398
| -7% | -$524K |
2013 Q2
7 quarters
|
|
268
lululemon athletica
LULU
$11.3B
| $7.03M | 0.07% |
109,820
-301,144
| -73% | -$19.3M |
2014 Q4
1 quarter
|
|
269
Stryker
SYK
$114B
| $7.01M | 0.07% |
75,947
-498
| -0.7% | -$46.4K |
2013 Q2
7 quarters
|
|
270
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$258M
| $6.96M | 0.07% |
186,617
+36,948
| +25% | +$1.33M |
2013 Q2
7 quarters
|
|
271
Saba Capital Income & Opportunities Fund II
SABA
$205M
| $6.96M | 0.07% |
483,688
-4,041
| -0.8% | -$58.5K |
2013 Q2
7 quarters
|
|
272
Hilltop Holdings
HTH
$2.09B
| $6.93M | 0.07% |
356,550
+70,908
| +25% | +$1.35M |
2013 Q2
7 quarters
|
|
273
First Trust Dorsey Wright Focus 5 ETF
FV
$3.91B
| $6.9M | 0.07% |
287,169
+90,959
| +46% | +$2.1M |
2014 Q1
4 quarters
|
|
274
Williams Companies
WMB
$88.9B
| $6.87M | 0.07% |
135,741
+22,678
| +20% | +$1.05M |
2013 Q2
7 quarters
|
|
275
Axos Financial
AX
$5.07B
| $6.84M | 0.07% |
294,140
+55,092
| +23% | +$1.21M |
2013 Q2
7 quarters
|
|
Similar funds
GIM
Baird's Q1 2015 Portfolio in Review
As of Q1 2015, Baird held 1,388 positions worth $9.8B, up 4.1% from $9.4B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Baird's Q1 2015 filing shows 121 new, 618 increased, 511 reduced and 78 closed positions. Its largest new stake was Hasbro: 657,109 shares worth $41.6M. The largest sale was HOSPIRA INC, an estimated $54.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.
- Baird's largest Q1 2015 buy was Hasbro: 657,109 shares worth $41.6M.
- Baird added most to AbbVie in Q1 2015, an estimated $65.4M increase.
- Baird's biggest Q1 2015 reduction was HOSPIRA INC, cutting an estimated $54.3M.
- Baird fully exited PVH in Q1 2015, selling an estimated $43M.
- Baird's ten largest holdings make up 14% of its $9.8B portfolio in Q1 2015.
- Baird opened 121 new positions and closed 78 in Q1 2015.
- Baird's portfolio value rose 4.1% quarter-over-quarter to $9.8B.
Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.